Thrombocytopenia Flashcards

1
Q

What is the most common cause of thrombocytopenia

A

Infection induced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the more common infectious causes of thrombocytopenia

A

Often with gram negative systemic infections, or HIV virals
Typically resolves once underlying infection is treated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the drugs that cause thrombocytopenia

A

Associated with many drugs including chemotherapy agents and antibiotics
Treatment is to withdrawal medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the pathophysiology behind HIT

A

• Typically results in a mild thrombocytopenia and places the patient at greater risk for clots.
• Typically post exposure a patient develops an antibody complex of anti-heparin/PF4 that activates platelets
• Typically occurs 5-14 days post exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the four Ts of HIT

A

• Four Ts
o Thrombocytopenia
o Thrombosis
o Timing
o Other causes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diagnostic testing for HIT

A

ElISA testing will test for the antibody complex
• Serotonin Release Assay will test for the ability for a patient’s serum plts to activate in the presence of heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Treatment for HIT

A

• Discontinue Heparin
• Can use Dabigatron instead, do NOT use LMWH, if longer anticoagulation is needed patient can be transitioned to warfarin
• Imaging studies to determine presence of clots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HIT treatment

A

• Discontinue Heparin
• Can use Dabigatron instead, do NOT use LMWH, if longer anticoagulation is needed patient can be transitioned to warfarin
• Imaging studies to determine presence of clots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Patho of ITP

A

• An immune mediated disorder the results in the destruction of platelets and the inhibition of plt release from megakarytocytes
• Associated with SLE, HIV, and Hep C infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ITP symptoms

A

• Mucosal bleeding, thrombocytopenia, bruising, petechiae, GI bleeding, heavy menstrual bleeding, and wet purpura, retinal hemorrhages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diagnostics for ITP

A

• CBC with thrombocytopenia
• Normal blood smear
• HIV, Hep C, and SLE testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ITP treatment

A

• Reserved for those with plt count <30k
• Without bleeding, thrombocytopenia, or impending bleeding
o Prednisone, IVIG, anti Rh globulin
• With bleeding, thrombocytopenia
o High doeglucocorticoids
o IVIG or antiRh
o Rituximab
o TPO receptor agonist if all other treatments fail
o Splenectomy if all treatments fail

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

TTP pathophysiology

A

• A hemolytic anemia, thrombocytopenia, renal failure, fever, and neurologic findings
• Related to a deficiency of or antibody to ADAMST13
• ADAMST13 is an enzyme which cleaves VWF. The ultra large VWF molecules are thought to contribute to pathologic platelet adhesion and aggregation.
• ADAMST13 <10% is typically when TTP is seen
• More common in women and pregnant or HIV infected individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Symptoms of TTP

A

• New thrombocytopenia with potential renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diagnostics for TTP

A

• Increased LDH, indirect bilirubin, and retic count
• Decreased haptoglobin
• Negative direct anti globulin test
• Peripheral blood smear: positive for polychormasia and schistocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

TTP diagnostics

A

• Increased LDH, indirect bilirubin, and retic count
• Decreased haptoglobin
• Negative direct anti globulin test
• Peripheral blood smear: positive for polychormasia and schistocytes

17
Q

Treatment for TTP

A

• Plasma exchanges
• Can use glucocorticoids and Rituximab in addition to plasma exchange

18
Q

Background of hemolytic uremic syndrome

A

• A microangiopathic hemolytic anemia and thrombocytopenia that results in renal damage and typically occurs after bloody diarrhea.
• Typically caused by h.pylori
• Atypical HUS is caused by a genetic defect that results in chronic complement activation

19
Q

Treatment for hemolytic uremic syndrome

A

• Supportive care; mainly hydration if associated with diarrhea
• AHUS can give eculizumab has efficacy in improving or preserving renal function